抗肥胖药物研究进展  

New drugs for the treatment of obesity

作　　者：马培奇 

机构地区：[1]上海医药行业协会,上海200003

出　　处：《上海医药》2013年第5期52-56,共5页Shanghai Medical & Pharmaceutical Journal

摘　　要：肥胖是全球主要公共卫生问题之一,会导致一系列的健康相关疾病风险,迫切需要有更安全、更有效且耐受性更好的新抗肥胖药物。本文概要介绍抗肥胖药物的现状和研究进展。ABSTRACT Obesity is a global health crisis resulting in major morbidity and premature death. The need for safe and efficacious drug therapies is great, and presently unmet. The goal of this review is to summarize advances in pharmacological agents for the treatment of obesity. KEY WORDS antiobesity drugs; lorcaserin hydrochloride; phentermine hydrochloride-topiramate; naltrexone-bupropion hydrochloride; liraglufide

关 键 词：抗肥胖药物 盐酸劳卡色林 盐酸芬特明-托吡酯 纳曲酮-盐酸安非他酮 利格鲁肽 

分 类 号：R977[医药卫生—药品]